Eyal Leibovitz

1.3k total citations
73 papers, 1.0k citations indexed

About

Eyal Leibovitz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eyal Leibovitz has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eyal Leibovitz's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers), Lipoproteins and Cardiovascular Health (10 papers) and Diabetes Management and Research (10 papers). Eyal Leibovitz is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (13 papers), Lipoproteins and Cardiovascular Health (10 papers) and Diabetes Management and Research (10 papers). Eyal Leibovitz collaborates with scholars based in Israel, Canada and United States. Eyal Leibovitz's co-authors include Dov Gavish, Ernesto L. Schiffrin, Mona Boaz, Reuven Zimlichman, Julio Wainstein, I Shapira, A Rubinstein, Mickey Scheinowitz, David Hasdai and Talin Ebrahimian and has published in prestigious journals such as Annals of the New York Academy of Sciences, The American Journal of Medicine and Nutrients.

In The Last Decade

Eyal Leibovitz

69 papers receiving 968 citations

Peers

Eyal Leibovitz
Comparison fields: 5 of 101
  • Endocrinology, Diabetes and Metabolism 319
  • Surgery 270
  • Cardiology and Cardiovascular Medicine 233
  • Physiology 179
  • Immunology 148
Replace José Puzo with:
José Puzo Spain
Jun Watanabe Japan
Sonoo Mizuiri Japan
Bernard Rosner United States
Vladimı́r Teplan Czechia
Gideon Charach Israel
Akintunde O. Akinkuolie United States
Marcelo Costa Batista Brazil
Rakesh S. Birjmohun Netherlands
Clara Barrios Spain
José Puzo Spain View profile →
Citations per field, relative to Eyal Leibovitz
Eyal Leibovitz · 1×
Citations per year, relative to Eyal Leibovitz
Eyal Leibovitz · 1×

Countries citing papers authored by Eyal Leibovitz

Since Specialization
Citations

This map shows the geographic impact of Eyal Leibovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyal Leibovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyal Leibovitz more than expected).

Fields of papers citing papers by Eyal Leibovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyal Leibovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyal Leibovitz. The network helps show where Eyal Leibovitz may publish in the future.

Co-authorship network of co-authors of Eyal Leibovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Eyal Leibovitz. A scholar is included among the top collaborators of Eyal Leibovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyal Leibovitz. Eyal Leibovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 6
2 3
3 1
4 11
5 11
6 37
7 48
8 7
9 4
10 20
11 101
12 1
13 8
14 40
15
Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
2
16 23
17 11
18 1
19 6
20 29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026